Tourette Syndrome: Clinical Trials

232 trials for Tourette Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

140 completed, 31 unknown, 26 recruiting, 17 terminated. 98 Not applicable, 45 Phase 2, 21 Phase 3, 15 Phase 1, 9 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable98Completed 50, Unknown 25, Recruiting 15, Terminated 3, Active not recruiting 2, Withdrawn 2, Not yet recruiting 1
Phase 245Completed 29, Recruiting 4, Terminated 4, Withdrawn 4, Unknown 2, Active not recruiting 1, Not yet recruiting 1
Phase 321Completed 18, Terminated 2, Active not recruiting 1
Phase 115Completed 9, Terminated 2, Withdrawn 2, Not yet recruiting 1, Recruiting 1
Phase 49Completed 6, Terminated 2, Unknown 1
Early Phase 13Completed 1, Unknown 1, Withdrawn 1

Follow Tourette Syndrome: new trials by email Literature Review of Tourette Syndrome trials Research Report on Tourette Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transcranial Ultrasound Stimulation for Tourette Syndrome
Focused ultrasound stimulation, Sham stimulation - Tourette Syndrome
Phase 1Not yet recruitingUniversity of Calgary202026-08-012026-07-13
Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)
Exposure and Response Prevention (ERP), Habit Reversal Training (HbRT, Psychoeducation and Supportive Intervention - Obsessive - Compulsive Disorder, Tic Disorder, Chronic Motor or Vocal
Not applicableRecruitingUniversity College London Hospitals402026-07-082026-07-27
SCI-110 in the Treatment of Tourette Syndrome
SCI-110, Placebo - Tourette Syndrome
Phase 2Not yet recruitingNeurothera Labs Inc.1642026-06-012026-04-21
Characterising Sleep Disorders in Children With Tourette Syndrome
Tourette Syndrome
Not yet recruitingSteffi Baker342026-03-012026-03-04
Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth
Universal approach, Selective approach, Outdoor therapy - Neurodevelopmental Outcomes, ADHD - Attention Deficit Disorder With Hyperactivity
Not applicableRecruitingSorlandet Hospital HF2402025-09-012025-10-02
Cognitive-psychophysiological Treatment for Tics in Young People With Tourette's Syndrome With or Without Biofeedback
Cognitive psychophysiological, Cognitive psychophysiological and Biofeedback - Tourette Syndrome, Tics
Not applicableRecruitingUniversité du Québec a Montréal1502025-04-152025-07-08
Trajectories of Change in Tourette Syndrome
Comprehensive Behavioral Intervention for Tics - Tourette Syndrome, Tic Disorders
Not applicableRecruitingUniversity of Minnesota302025-03-312026-07-17
Sensorimotor Integration in Patients With Tourette Syndrome
Tourette Disorder, Sensory Gating
CompletedI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio602025-03-202025-12-18
CBIT+TMS R33 Phase
CBIT +cTBS, CBIT +sham cTBS - Tics, Tourette Syndrome
Phase 2RecruitingUniversity of Minnesota602025-02-272026-05-20
Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome
Multimodal electrophysiological recordings - Tourette Syndrome
Not applicableRecruitingUniversity Hospital, Bordeaux102025-02-172025-04-03
Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics
Habit Reversal Training - Tics, Tourette Disorder
Not applicableRecruitingUniversity of Utah62025-02-112025-05-28
Effect of RNS in Treatment-refractory Tourette's Syndrome
Responsive Neurostimulation (RNS) - Tourette Syndrome
Not applicableRecruitingXuanwu Hospital, Beijing102025-02-052025-01-21
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
This study involves no intervention. - Tourette Syndrome, Tic Disorder
RecruitingVanderbilt University Medical Center3512024-10-242025-11-24
Multitarget Stereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome
New Target DBS, CM-DBS, Sham Stimulation - Tourette Syndrome, Deep Brain Stimulation
Not applicableRecruitingBeijing Tiantan Hospital52024-10-012025-05-22
Effectiveness of Symptom Management Application on Parental Care Ability of Children With Tourette Syndrome
Symptom Management APP group, health education instructions group - Tourette Syndrome, Tic Disorder
Not applicableUnknownNational Taipei University of Nursing and Health Sciences1802024-09-252024-10-03
Serotonin Control of Impulsivity in Tourette Disorder
Administration of a PET radiotracer - Tourette Disorder
Phase 2RecruitingHospices Civils de Lyon252024-09-242024-12-04
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Sertraline, Placebo - Neurodevelopmental Disorders, Autism
Phase 2RecruitingHolland Bloorview Kids Rehabilitation Hospital1302024-09-162026-07-27
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
Gemlapodect, Placebo - Tourette Syndrome
Phase 2Active not recruitingNoema Pharma AG1642024-09-102026-03-09
A Multicenter Pediatric Deep Brain Stimulation Registry
Dystonia, Epilepsy in Children
RecruitingBoston Children's Hospital1002024-07-302026-03-18
Remote Delivery of a Mindfulness-based Intervention for Tics
mindfulness-based intervention for tics (MBIT), psychoeducation with relaxation and supportive therapy (PRST) - Tourette Syndrome, Tourette's Disorder
Not applicableRecruitingJohns Hopkins University1502024-05-232026-05-11

Showing 20 of 232. Sign in to see all of them.

Narrower conditions

Tic Disorders (73)  ·  Tics (56)  ·  Obsessive-Compulsive Disorder (18)  ·  Attention Deficit Disorder with Hyperactivity (12)  ·  Mental Disorders (12)  ·  Movement Disorders (9)  ·  Anxiety Disorders (7)  ·  Neurologic Manifestations (7)  ·  Parkinson Disease (6)  ·  Rare Diseases (6)  ·  Brain Diseases (5)  ·  Depression (5)  ·  Dystonia (4)  ·  Nervous System Diseases (4)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (232)  ·  Genetic Diseases, Inborn (232)  ·  Heredodegenerative Disorders, Nervous System (232)  ·  Neurodegenerative Diseases (231)  ·  Basal Ganglia Diseases (230)  ·  Central Nervous System Diseases (229)  ·  Neurodevelopmental Disorders (229)  ·  Nervous System Diseases (228)  ·  Brain Diseases (227)  ·  Movement Disorders (223)  ·  Mental Disorders (220)  ·  Tic Disorders (159)  ·  Pathological Conditions, Signs and Symptoms (75)  ·  Signs and Symptoms (75)  ·  Neurologic Manifestations (66)

Interventions

Aripiprazole (10)  ·  valbenazine (8)  ·  Deep Brain Stimulation (6)  ·  Transcranial Magnetic Stimulation (6)  ·  ecopipam (5)  ·  deutetrabenazine (4)  ·  Behavior Therapy (3)  ·  Palliative Care (3)  ·  ABX-1431 (2)  ·  Biofeedback, Psychology (2)  ·  Cycloserine (2)  ·  Demography (2)  ·  Dronabinol (2)  ·  Electroencephalography (2)  ·  Guanfacine (2)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (12)  ·  Johns Hopkins University (9)  ·  Neurocrine Biosciences (8)  ·  University of Florida (8)  ·  Yale University (8)  ·  Emalex Biosciences Inc. (6)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (6)  ·  Vanderbilt University Medical Center (6)  ·  National Center for Research Resources (NCRR) (5)  ·  National Institute of Mental Health (NIMH) (5)  ·  University of Minnesota (5)  ·  University of Utah (5)  ·  Children's Hospital Medical Center, Cincinnati (4)  ·  Karolinska Institutet (4)  ·  Massachusetts General Hospital (4)

Countries

United States (136)  ·  Germany (21)  ·  Canada (20)  ·  France (18)  ·  Italy (12)  ·  Hungary (10)  ·  China (9)  ·  Poland (8)  ·  Spain (8)  ·  Taiwan (8)  ·  South Korea (6)  ·  United Kingdom (6)  ·  Israel (5)  ·  Mexico (5)  ·  Sweden (5)

Top investigators

Eva Kohegyi, MD (5)  ·  David A Isaacs, MD, MPH (3)  ·  Emily J Ricketts, PhD (3)  ·  Joseph F McGuire, PhD (3)  ·  Michael H. Bloch, MD, MS (3)  ·  Michael Okun, MD (3)  ·  Shannon Bennett, PhD (3)  ·  Barbara J Coffey, MD, MS (2)  ·  Christine Conelea, PhD (2)  ·  David Isaacs, MD, MPH (2)  ·  Donald Gilbert, MD (2)

Results publications

PMID 20483969, PMID 22868933, PMID 24001701, PMID 24144615, PMID 25988365, PMID 26763495, PMID 28202705, PMID 29029679, PMID 11202129, PMID 11235929, PMID 11530448, PMID 11886028, PMID 12541004, PMID 12723873, PMID 12874491, PMID 14980369, PMID 15107196, PMID 15965209, PMID 16259942, PMID 16387997, PMID 16393016, PMID 16554257, PMID 16970874, PMID 18307557, PMID 18348596, PMID 18625864, PMID 18696285, PMID 19170198, PMID 19242384, PMID 19284553, PMID 19864199, PMID 19913651, PMID 20331933, PMID 20579510, PMID 20841416, PMID 20885982, PMID 21445724, PMID 21555779, PMID 22585765, PMID 22741094, PMID 23044532, PMID 23538086, PMID 23572168, PMID 23731910, PMID 24021518, PMID 24832397, PMID 24856571, PMID 24906033, PMID 25325069, PMID 25546850

NIH funding

2016 (3), 2023 (3), 2017 (2), 2018 (2), UL1TR002345 (2), 2008 (1), 2019 (1), F31MH096375 (1), K23MH113884 (1), K24MH087913 (1), P50MH077248 (1), R01AT012455 (1), R01MH045358 (1), R01MH045802 (1), R01MH069877 (1)